We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Safety Study of ZD4054 in Prior Chemotherapy Treated Patients With Metastatic Hormone-resistant Prostate Cancer (DAPROCA-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01000948
Recruitment Status : Terminated (A consequence of the results of the ENTHUSE phase III study program)
First Posted : October 23, 2009
Last Update Posted : January 8, 2014
Sponsor:
Collaborator:
Rigshospitalet, Denmark
Information provided by (Responsible Party):
Michael Borre, Aarhus University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : July 2011
  Study Completion Date : July 2011